Skip to content

Home-based Physical Trainings for Reducing Cardiovascular Risk

Home-based Physical Trainings for Reducing Cardiovascular Risk

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05146076
Enrollment
150
Registered
2021-12-06
Start date
2017-11-01
Completion date
2022-07-01
Last updated
2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome

Brief summary

Prospective intervention study among metabolic syndrome patients, investigating the effects of 12 weeks home-based physical training programme with telemonitoring on the anthropometric parameters, the exercise tolerance and other cardio-metabolic risk factors of the metabolic syndrome.

Detailed description

Prospective intervention study among metabolic syndrome patients, investigating the effects of 12 weeks home-based physical training programme with telemonitoring on the anthropometric and laboratory parameters, the exercise tolerance and other cardio-metabolic and other psycho-social (anxiety, depression, vital exhaustion , sleep disturbances) risk factors of the metabolic syndrome.

Interventions

home-based physical training minimum 150 min./week with telemonitoring

OTHERinstitutional physical training

institutional physical training supervised by physiotherapist 2-3 times 60 min./week

Sponsors

István Kósa
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* voluntary patients aged between 25 and 70 years * low level of regular physical activity, less than 30 min./ week * basic IT skills * 3 risk factors present out of the 5 metabolic risk factors from the followings: 1. waist circumference (WC) above 102 cm in men and above 88 cm in women 2. proved type 2 diabetes mellitus (T2DM) or fasting plasma glucose level above 5,6 mmol/l 3. treated hypertension or spontaneous blood pressure higher or equivalent than 130/ 85 mmHg 4. treated hypertriglyceridaemia or serum triglyceride level above 1,7 mmol/l 5. serum HDL cholesterol level under 1,03 mmol/l in men or 1,3 mmol/l in women

Exclusion criteria

* any upcoming planned invasive cardiological intervention * uncontrolled hypertension * type one diabetes mellitus (T1DM) * T2DM which needed more than 1 dose insulin per day * chronic heart failure * chronic renal failure * serious cognitive disfunction * lack of cooperation * any of known disease or condition that seriously affect the mental and legal capacity * any other conditions inhibiting regular physical trainings

Design outcomes

Primary

MeasureTime frameDescription
waist circumference (WC) navel12 weekswaist circumference measured at navel level
Six minutes walk distance (6MWD)12 weeks6 minutes walk distance

Secondary

MeasureTime frameDescription
body parameter 212 weekship circumference measured in cm-s
body parameter 312 weeksBMI calculated from weight (kg-s) and height (m-s)
body parameter 412 weeksbody composition parameters (fat / muscle / water ratio)
functional parameter 112 weeksstress ECG duration time measured in sec
psychological test result 212 weeksDepression score
psychological test result 312 weeksvital exhaustion score
psychological test result 412 weekshealth locus of control score
psychological test result 512 weeksperceived stress score
laboratory parameter 212 weeksfasting plasma glucose (+PG) measured in mmol/l
laboratory parameter 312 weekstriglyceride (TG), measured in mmol/l
laboratory parameter 412 weeksHDL cholesterol, measured in mmol/l
laboratory parameter 512 weekstotal-cholesterol measured in mmol/l
psychological test result 112 weeksAnxiety score
psychological test result 612 weeksself-control score
laboratory parameter 112 weeksglycated haemoglobin (HbA1c) measured in percentage
body parameter 112 weeksbody weight measured in kg-s

Countries

Hungary

Contacts

Primary ContactIstván Kósa, Med. habil.
kosa.istvan@med.u-szeged.hu+36703321652
Backup ContactÉva Máthéné Köteles
mathene.koteles.eva.szilvia@szte.hu+36 30 272 5994

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026